Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
Clinical trial NCT06327178 · RECRUITING
Trial details
- NCT number
- NCT06327178
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-01
- Primary completion
- 2025-04-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.